[HTML][HTML] Glypican-3 is a prognostic factor and an immunotherapeutic target in hepatocellular carcinoma

Y Haruyama, H Kataoka - World journal of gastroenterology, 2016 - ncbi.nlm.nih.gov
… -3 expression is a significant prognostic factor that predicts poor outcome of patients … target
for the development of novel therapies for HCC, and preclinical and clinical trials targeting

Prognostic factors in advanced non-small cell lung cancer patients treated with immunotherapy

D Rocco, L Della Gravara, A Ragone, L Sapio… - Cancers, 2023 - mdpi.com
… Ratio (NLR) has been associated with a poor prognostic value in NSCLC patients receiving
chemotherapy, targeted therapy, and immunotherapy. In fact, NSCLC patients with a high …

Predictive Factors of Immunotherapy in Gastric Cancer: A 2024 Update

V Bintintan, C Burz, I Pintea, A Muntean, D Deleanu… - Diagnostics, 2024 - mdpi.com
… in GC tissues, ACVR1 could be a promising target for GC immunotherapy [49]. Fc gamma
receptor … -type macrophages and relevant prognostic factors for predicting immunotherapy and …

Targeted therapies to improve tumor immunotherapy

J Begley, A Ribas - Clinical cancer research, 2008 - AACR
… approaches with immunotherapy. In this article, we postulate that targeted agents against key
Prognostic factors related to clinical response in patients with metastatic melanoma treated …

Serum cytokine levels and other associated factors as possible immunotherapeutic targets and prognostic indicators for lung cancer

Y Zhao, S Jia, K Zhang, L Zhang - Frontiers in oncology, 2023 - frontiersin.org
… biomarkers for lung cancer and predict the effectiveness of targeted immunotherapy. …
However, a prognostic factor cannot provide information on a specific therapy’s advantages. …

Inflammatory factors are associated with prognosis of non-small cell lung cancer patients receiving immunotherapy: a meta-analysis

W Tong, H Xu, J Tang, N Zhao, D Zhou, C Chen… - Scientific Reports, 2024 - nature.com
… -based prognostic factors, such as C-reactive protein (CRP), on the prognosis of NSCLC …
patients, evaluating factors such as CRP, the modified Glasgow Prognostic Score (mGPS), …

Prognostic factors in renal cell carcinoma

A Volpe, JJ Patard - World journal of urology, 2010 - Springer
… was considered an important prognostic factor in the era of immunotherapy [81]. It … prognostic
factor in mRCC. This has been clearly established both in the immunotherapy and targeted

Pyroptosis-related genes prognostic model for predicting targeted therapy and immunotherapy response in soft tissue sarcoma

M Liu, Q Li, Y Liang - Frontiers in Pharmacology, 2023 - frontiersin.org
… Afterward, it was determined whether PRGs-risk scores may be independent prognostic
factors through univariate and multivariate cox regression analyses. The high PRGs-risk score …

Predicting response of immunotherapy and targeted therapy and prognosis characteristics for renal clear cell carcinoma based on m1A methylation regulators

L Li, H Tan, J Zhou, F Hu - Scientific Reports, 2023 - nature.com
Prognostic signature of the four related regulators in the training set of … prognostic factors
for KIRC OS. (A,B) The training set of forrest plot of the independent prognostic factors in KIRC. (…

PRAME Expression: A Target for Cancer Immunotherapy and a Prognostic Factor in Uveal Melanoma

MC Gelmi, G Gezgin… - … & Visual Science, 2023 - iovs.arvojournals.org
… Conclusions: We confirm that PRAME is associated with poor prognosis in UM and has a
strong connection with extra copies of 8q. We show that PRAME-specific immunotherapy in an …